Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Price

Showing results (11-20 of 260) with videos related to

Pageof 26
Sort By:
JAMA|November 3, 2012
Measured drug effect and cardiovascular outcomes in patients receiving platelet P2Y12 receptor antagonists: clarifying the time and place for intensive inhibitionMatthew J Price
The American Journal of Cardiology|January 27, 2009
Monitoring platelet function to reduce the risk of ischemic and bleeding complicationsMatthew J Price
Interventional Cardiology Clinics|September 10, 2017
Transcatheter Closure of Patent Foramen Ovale: Devices and TechniqueMatthew J Price
Journal of the American College of Cardiology|September 6, 2014
Diabetes mellitus and clopidogrel response variabilityMatthew J Price
Lancet (London, England)|July 30, 2013
Platelet reactivity after coronary stentingMatthew J Price
JACC. Cardiovascular Interventions|June 11, 2016
The Pharmacodynamics of Switching Between P2Y12 Receptor AntagonistsMatthew J Price
Interventional Cardiology Clinics|June 6, 2017
Prevention and Management of Complications of Left Atrial Appendage Closure DevicesMatthew J Price
Journal of the American College of Cardiology|April 4, 2015
The optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: chasing a mirageMatthew J Price
Interventional Cardiology Clinics|September 14, 2020
Abbreviated Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in High Bleeding Risk Patients: LEADERS-FREE and ONYX ONEMatthew J Price
Interventional Cardiology Clinics|November 26, 2016
Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary InterventionMatthew J Price
Pageof 26

Showing results (11-20 of 260) with videos related to

Sort By:
Pageof 26
JAMA|November 3, 2012
Measured drug effect and cardiovascular outcomes in patients receiving platelet P2Y12 receptor antagonists: clarifying the time and place for intensive inhibitionMatthew J Price
The American Journal of Cardiology|January 27, 2009
Monitoring platelet function to reduce the risk of ischemic and bleeding complicationsMatthew J Price
Interventional Cardiology Clinics|September 10, 2017
Transcatheter Closure of Patent Foramen Ovale: Devices and TechniqueMatthew J Price
Journal of the American College of Cardiology|September 6, 2014
Diabetes mellitus and clopidogrel response variabilityMatthew J Price
Lancet (London, England)|July 30, 2013
Platelet reactivity after coronary stentingMatthew J Price
JACC. Cardiovascular Interventions|June 11, 2016
The Pharmacodynamics of Switching Between P2Y12 Receptor AntagonistsMatthew J Price
Interventional Cardiology Clinics|June 6, 2017
Prevention and Management of Complications of Left Atrial Appendage Closure DevicesMatthew J Price
Journal of the American College of Cardiology|April 4, 2015
The optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: chasing a mirageMatthew J Price
Interventional Cardiology Clinics|September 14, 2020
Abbreviated Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in High Bleeding Risk Patients: LEADERS-FREE and ONYX ONEMatthew J Price
Interventional Cardiology Clinics|November 26, 2016
Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary InterventionMatthew J Price
Pageof 26